The Clinical Manifestations and Genetic Implications of Baraitser–Winter Syndrome Type 2

Abstract

An 18-year-old Caucasian male was born by cesarean section weighing 2.6 kg (5 lb 14 oz) at birth after an uncomplicated pregnancy with no perinatal complications. Around 4 to 5 months of age, the patient's mother initially became concerned as he was experiencing signs of developmental delay and a mild floppy tone, in addition to facial features that resembled some form of mental retardation. The patient's older brother also experienced similar developmental symptoms and facial features that presented around the same age period as our patient. It was initially thought to be Down syndrome; however, both the patient and his brother tested negative for Down syndrome on chromosomal analyses. There was also a question of whether the patient had some form of autism spectrum disorder, but doctors were unable to specifically confirm this. Now at the age of 18 years, the patient has no understandable speech with distinctive facial features such as a broad nasal bridge and prominent epicanthic folds, lissencephaly, smaller than average head size, intellectual disability, and hearing loss. It was discovered, through trio-based exome sequencing, that the patient had a de novo missense mutation (p.Ser155Phe) in the ACTG1 gene, which has been linked to the rare syndrome known as Baraister–Winter syndrome type 2. Baraitser–Winter syndrome 2 is a unique variant that is clinically similar to Baraitser–Winter syndrome type 1; however, only seven previous cases have been reported.

Keywords

Baraitser–Winter syndrome type 2 - ACTG1 gene mutations - de novo

• References

• 1 Rivière J-B, van Bon BW, Hoischen A , et al. De novo mutations in the actin genes ACTB and ACTG1 cause Baraitser-Winter syndrome. Nat Genet 2012; 44 (4) 440-444 , S1–S2
• 2 Baraitser M, Winter RM. Iris coloboma, ptosis, hypertelorism, and mental retardation: a new syndrome. J Med Genet 1988; 25 (1) 41-43
• 3 Verloes A, Di Donato N, Masliah-Planchon J , et al. Baraitser-Winter cerebrofrontofacial syndrome: delineation of the spectrum in 42 cases. Eur J Hum Genet 2015; 23 (3) 292-301
• 4 Pallotta R. Iris coloboma, ptosis, hypertelorism, and mental retardation: a new syndrome possibly localised on chromosome 2. J Med Genet 1991; 28 (5) 342-344
• 5 Le Marec B, Odent S, Urvoy M. A new syndrome with ptosis, coloboma and mental retardation. Genet Couns 1992; 3 (2) 119-120
• 6 Fryns J-P. Previously apparently undescribed syndrome: shallow orbits, ptosis, coloboma, trigonocephaly, gyral malformations, and mental and growth retardation. Am J Med Genet 1996; 64 (3) 521-522
• 7 Vandekerckhove J, Weber K. At least six different actins are expressed in a higher mammal: an analysis based on the amino acid sequence of the amino-terminal tryptic peptide. J Mol Biol 1978; 126 (4) 783-802
• 8 Yao J, Sasaki Y, Wen Z, Bassell GJ, Zheng JQ. An essential role for beta-actin mRNA localization and translation in Ca2+-dependent growth cone guidance. Nat Neurosci 2006; 9 (10) 1265-1273
• 9 Dugina V, Zwaenepoel I, Gabbiani G, Clément S, Chaponnier C. Beta and gamma-cytoplasmic actins display distinct distribution and functional diversity. J Cell Sci 2009; 122 (Pt 16) 2980-2988
• 10 Höfer D, Ness W, Drenckhahn D. Sorting of actin isoforms in chicken auditory hair cells. J Cell Sci 1997; 110 (Pt 6) 765-770
• 11 Nunoi H, Yamazaki T, Tsuchiya H , et al. A heterozygous mutation of beta-actin associated with neutrophil dysfunction and recurrent infection. Proc Natl Acad Sci U S A 1999; 96 (15) 8693-8698
• 12 Procaccio V, Salazar G, Ono S , et al. A mutation of beta -actin that alters depolymerization dynamics is associated with autosomal dominant developmental malformations, deafness, and dystonia. Am J Hum Genet 2006; 78 (6) 947-960
• 13 Zhu M, Yang T, Wei S , et al. Mutations in the gamma-actin gene (ACTG1) are associated with dominant progressive deafness (DFNA20/26). Am J Hum Genet 2003; 73 (5) 1082-1091
• 14 Hoischen A, van Bon BW, Rodríguez-Santiago B , et al. De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndrome. Nat Genet 2011; 43 (8) 729-731
• 15 Vissers LE, de Ligt J, Gilissen C , et al. A de novo paradigm for mental retardation. Nat Genet 2010; 42 (12) 1109-1112
• 16 O'Roak BJ, Deriziotis P, Lee C , et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet 2011; 43 (6) 585-589
• 17 Girard SL, Gauthier J, Noreau A , et al. Increased exonic de novo mutation rate in individuals with schizophrenia. Nat Genet 2011; 43 (9) 860-863